Women’s Health Devices Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032
Description
Growth Factors of Women's Health Devices Market
The global women’s health devices market is witnessing a significant surge in demand, underpinned by increasing awareness about gender-specific healthcare needs, a growing female geriatric population, and rapid innovations in medical technology. According to a recent report by Fortune Business Insights, the market size stood at USD 38.31 billion in 2023 and is expected to reach USD 63.82 billion by 2030, growing at a compound annual growth rate (CAGR) of 7.6% during the forecast period.
This growth trajectory underscores the increasing adoption of specialized diagnostic and therapeutic devices tailored to women’s health conditions such as reproductive disorders, breast cancer, osteoporosis, and pregnancy-related complications. The global healthcare ecosystem is undergoing a strategic shift from gender-neutral approaches to personalized care—placing women’s health at the center of medical innovation and policy focus.
Key Drivers Fueling Market Growth
1. Rising Prevalence of Female-Specific Conditions
A growing number of women are being diagnosed with gynecological disorders, breast cancer, and other chronic diseases requiring specialized treatment. For example, breast cancer is now the most commonly diagnosed cancer among women worldwide, prompting increased demand for imaging devices and early detection solutions.
2. Increasing Demand for Fertility and Pregnancy Management Devices
With changing lifestyle patterns and a higher median age of first-time mothers, fertility devices, ovulation kits, and maternal monitors are becoming increasingly relevant. These tools support both preventive care and treatment, driving market value.
3. Technological Advancements
From wearable breast pumps to AI-integrated ultrasound machines and telehealth-enabled gynecological diagnostics, technology is revolutionizing women’s healthcare. Devices that offer real-time monitoring and personalized feedback are especially popular among millennial and Gen Z populations.
4. Government Initiatives and Awareness Campaigns
Public health agencies around the world are launching programs to educate women about preventive screenings, contraception, and menstrual health. Subsidized access to diagnostic imaging and contraceptive devices in emerging economies further contributes to market growth.
Market Segmentation Snapshot
The women’s health devices market is segmented based on product type, application, and end user:
By Product Type: Diagnostic imaging devices, surgical devices, contraceptive devices, and critical care devices.
By Application:
Reproductive health, oncology, bone health, and cardiovascular health.
By End User: Hospitals, gynecology clinics, diagnostic centers, and home healthcare.
Among these, diagnostic imaging devices hold the largest market share, thanks to increasing use in breast cancer detection and routine gynecological exams. The contraceptive devices segment is projected to register high growth, especially in Asia and Africa, due to expanding government-supported birth control programs.
Regional Insights
The market is analyzed across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa:
North America dominates the market with the largest revenue share, fueled by high awareness, widespread health insurance coverage, and advanced diagnostic infrastructure.
Europe follows closely with supportive healthcare policies and increasing investment in women-centric research.
Asia-Pacific is the fastest-growing region, benefiting from growing urbanization, rising incomes, and government-led maternal and child health programs.
Latin America and the Middle East & Africa are showing gradual adoption, supported by foreign healthcare aid and expanding private sector investment.
Competitive Landscape
The global women’s health devices market features several key players focused on innovation, strategic mergers, and regional expansion. Some of the leading companies include:
GE HealthCare
Siemens Healthineers
Koninklijke Philips N.V.
Hologic, Inc.
F. Hoffmann-La Roche Ltd
Bayer AG
Boston Scientific Corporation
CooperSurgical, Inc.
Fujifilm Holdings Corporation
Medtronic
These companies are investing heavily in R&D to launch cutting-edge solutions in breast health, reproductive technology, and non-invasive diagnostic imaging.
Conclusion
As the world moves toward more personalized and inclusive healthcare, the women’s health devices market stands at the forefront of innovation and impact. With robust growth projections and increasing global emphasis on female wellbeing, the industry offers a wealth of opportunities for medical device manufacturers, healthcare providers, and investors alike.
ATTRIBUTE DETAILS
Study Period 2019-2032
Base Year 2024
Estimated Year 2025
Forecast Period 2025-2032
Historical Period 2019-2023
Growth Rate CAGR of 9.7% from 2025-2032
Unit Value (USD billion)
Segmentation By Application, End-user, and Region
By Application
General Health & Wellness
Cancers & Other Chronic Diseases
Reproductive Health
Pregnancy & Nursing Care
Pelvic & Uterine Healthcare
Others
By End-user Hospitals & Clinics
Home Healthcare
Others
By Region North America (By Application, By End-user, and By Country)
U.S.
Canada
Europe (By Application, By End-user, and By Country/Sub-Region)
Germany
U.K.
France
Italy
Spain
Rest of Europe
Asia Pacific (By Application, By End-user, and By Country/Sub-Region)
China
Japan
India
Australia
Rest of Asia Pacific
Rest of the World (By Application
and By End-user)
Please Note:
It will take 5-6 business days to complete the report upon order confirmation.
The global women’s health devices market is witnessing a significant surge in demand, underpinned by increasing awareness about gender-specific healthcare needs, a growing female geriatric population, and rapid innovations in medical technology. According to a recent report by Fortune Business Insights, the market size stood at USD 38.31 billion in 2023 and is expected to reach USD 63.82 billion by 2030, growing at a compound annual growth rate (CAGR) of 7.6% during the forecast period.
This growth trajectory underscores the increasing adoption of specialized diagnostic and therapeutic devices tailored to women’s health conditions such as reproductive disorders, breast cancer, osteoporosis, and pregnancy-related complications. The global healthcare ecosystem is undergoing a strategic shift from gender-neutral approaches to personalized care—placing women’s health at the center of medical innovation and policy focus.
Key Drivers Fueling Market Growth
1. Rising Prevalence of Female-Specific Conditions
A growing number of women are being diagnosed with gynecological disorders, breast cancer, and other chronic diseases requiring specialized treatment. For example, breast cancer is now the most commonly diagnosed cancer among women worldwide, prompting increased demand for imaging devices and early detection solutions.
2. Increasing Demand for Fertility and Pregnancy Management Devices
With changing lifestyle patterns and a higher median age of first-time mothers, fertility devices, ovulation kits, and maternal monitors are becoming increasingly relevant. These tools support both preventive care and treatment, driving market value.
3. Technological Advancements
From wearable breast pumps to AI-integrated ultrasound machines and telehealth-enabled gynecological diagnostics, technology is revolutionizing women’s healthcare. Devices that offer real-time monitoring and personalized feedback are especially popular among millennial and Gen Z populations.
4. Government Initiatives and Awareness Campaigns
Public health agencies around the world are launching programs to educate women about preventive screenings, contraception, and menstrual health. Subsidized access to diagnostic imaging and contraceptive devices in emerging economies further contributes to market growth.
Market Segmentation Snapshot
The women’s health devices market is segmented based on product type, application, and end user:
By Product Type: Diagnostic imaging devices, surgical devices, contraceptive devices, and critical care devices.
By Application:
Reproductive health, oncology, bone health, and cardiovascular health.
By End User: Hospitals, gynecology clinics, diagnostic centers, and home healthcare.
Among these, diagnostic imaging devices hold the largest market share, thanks to increasing use in breast cancer detection and routine gynecological exams. The contraceptive devices segment is projected to register high growth, especially in Asia and Africa, due to expanding government-supported birth control programs.
Regional Insights
The market is analyzed across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa:
North America dominates the market with the largest revenue share, fueled by high awareness, widespread health insurance coverage, and advanced diagnostic infrastructure.
Europe follows closely with supportive healthcare policies and increasing investment in women-centric research.
Asia-Pacific is the fastest-growing region, benefiting from growing urbanization, rising incomes, and government-led maternal and child health programs.
Latin America and the Middle East & Africa are showing gradual adoption, supported by foreign healthcare aid and expanding private sector investment.
Competitive Landscape
The global women’s health devices market features several key players focused on innovation, strategic mergers, and regional expansion. Some of the leading companies include:
GE HealthCare
Siemens Healthineers
Koninklijke Philips N.V.
Hologic, Inc.
F. Hoffmann-La Roche Ltd
Bayer AG
Boston Scientific Corporation
CooperSurgical, Inc.
Fujifilm Holdings Corporation
Medtronic
These companies are investing heavily in R&D to launch cutting-edge solutions in breast health, reproductive technology, and non-invasive diagnostic imaging.
Conclusion
As the world moves toward more personalized and inclusive healthcare, the women’s health devices market stands at the forefront of innovation and impact. With robust growth projections and increasing global emphasis on female wellbeing, the industry offers a wealth of opportunities for medical device manufacturers, healthcare providers, and investors alike.
ATTRIBUTE DETAILS
Study Period 2019-2032
Base Year 2024
Estimated Year 2025
Forecast Period 2025-2032
Historical Period 2019-2023
Growth Rate CAGR of 9.7% from 2025-2032
Unit Value (USD billion)
Segmentation By Application, End-user, and Region
By Application
General Health & Wellness
Cancers & Other Chronic Diseases
Reproductive Health
Pregnancy & Nursing Care
Pelvic & Uterine Healthcare
Others
By End-user Hospitals & Clinics
Home Healthcare
Others
By Region North America (By Application, By End-user, and By Country)
U.S.
Canada
Europe (By Application, By End-user, and By Country/Sub-Region)
Germany
U.K.
France
Italy
Spain
Rest of Europe
Asia Pacific (By Application, By End-user, and By Country/Sub-Region)
China
Japan
India
Australia
Rest of Asia Pacific
Rest of the World (By Application
and By End-user)
Please Note:
It will take 5-6 business days to complete the report upon order confirmation.
Table of Contents
110 Pages
- 1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
- 2. Executive Summary
- 3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
- 3.4. Market Trends
- 4. Key Insights
- 4.1. Prevalence of Key Disease Indications, By Key Countries/ Regions, 2024
- 4.2. Overview: Start-ups and Innovations in the Women’s Health Devices Market
- 4.3. Key Industry Developments – Mergers, Acquisitions, and Partnerships
- 4.4. Impact of COVID-19 on the Women’s Health Devices Market
- 5. Global Women’s Health Devices Market Analysis, Insights and Forecast, 2019-2032
- 5.1. Market Analysis, Insights and Forecast – By Application
- 5.1.1. General Health & Wellness
- 5.1.2. Cancers & Other Chronic Diseases
- 5.1.3. Reproductive Health
- 5.1.4. Pregnancy & Nursing Care
- 5.1.5. Pelvic & Uterine Healthcare
- 5.1.6. Others
- 5.2. Market Analysis, Insights and Forecast – By End User
- 5.2.1. Hospitals & Clinics
- 5.2.2. Home Healthcare
- 5.2.3. Others
- 5.3. Market Analysis, Insights and Forecast – By Region
- 5.3.1. North America
- 5.3.2. Europe
- 5.3.3. Asia Pacific
- 5.3.4. Rest of the World
- 6. North America Women’s Health Devices Market Analysis, Insights and Forecast, 2019-2032
- 6.1. Market Analysis, Insights and Forecast – By Application
- 6.1.1. General Health & Wellness
- 6.1.2. Cancers & Other Chronic Diseases
- 6.1.3. Reproductive Health
- 6.1.4. Pregnancy & Nursing Care
- 6.1.5. Pelvic & Uterine Healthcare
- 6.1.6. Others
- 6.2. Market Analysis, Insights and Forecast– By End User
- 6.2.1. Hospitals & Clinics
- 6.2.2. Home Healthcare
- 6.2.3. Others
- 6.3. Market Analysis, Insights and Forecast – By Country
- 6.3.1. U.S.
- 6.3.2. Canada
- 7. Europe Women’s Health Devices Market Analysis, Insights and Forecast, 2019-2032
- 7.1. Market Analysis, Insights and Forecast– By Application
- 7.1.1. General Health & Wellness
- 7.1.2. Cancers & Other Chronic Diseases
- 7.1.3. Reproductive Health
- 7.1.4. Pregnancy & Nursing Care
- 7.1.5. Pelvic & Uterine Healthcare
- 7.1.6. Others
- 7.2. Market Analysis, Insights and Forecast– By End User
- 7.2.1. Hospitals & Clinics
- 7.2.2. Home Healthcare
- 7.2.3. Others
- 7.3. Market Analysis, Insights and Forecast– By Country/ Sub-Region
- 7.3.1. U.K.
- 7.3.2. Germany
- 7.3.3. France
- 7.3.4. Spain
- 7.3.5. Italy
- 7.3.6. Rest of Europe
- 8. Asia Pacific Women’s Health Devices Market Analysis, Insights and Forecast, 2019-2032
- 8.1. Market Analysis, Insights and Forecast– By Application
- 8.1.1. General Health & Wellness
- 8.1.2. Cancers & Other Chronic Diseases
- 8.1.3. Reproductive Health
- 8.1.4. Pregnancy & Nursing Care
- 8.1.5. Pelvic & Uterine Healthcare
- 8.1.6. Others
- 8.2. Market Analysis, Insights and Forecast– By End User
- 8.2.1. Hospitals & Clinics
- 8.2.2. Home Healthcare
- 8.2.3. Others
- 8.3. Market Analysis, Insights and Forecast– By Country/ Sub-Region
- 8.3.1. Japan
- 8.3.2. China
- 8.3.3. India
- 8.3.4. Australia
- 8.3.5. Rest of Asia Pacific
- 9. Rest of World Women’s Health Devices Market Analysis, Insights and Forecast, 2019-2032
- 9.1. Market Analysis, Insights and Forecast– By Application
- 9.1.1. General Health & Wellness
- 9.1.2. Cancers & Other Chronic Diseases
- 9.1.3. Reproductive Health
- 9.1.4. Pregnancy & Nursing Care
- 9.1.5. Pelvic & Uterine Healthcare
- 9.1.6. Others
- 9.2. Market Analysis, Insights and Forecast– By End User
- 9.2.1. Hospitals & Clinics
- 9.2.2. Home Healthcare
- 9.2.3. Others
- 10. Competitive Analysis
- 10.1. Global Market Share Analysis (2024)
- 10.2. Company Profiles (Overview, Products, SWOT Analysis, Recent Developments, Strategies, Financials (Based On Availability))
- 10.2.1. Coloplast A/S
- 10.2.1.1. Overview,
- 10.2.1.2. Products,
- 10.2.1.3. SWOT Analysis,
- 10.2.1.4. Recent Developments,
- 10.2.1.5. Strategies,
- 10.2.1.6. Financials (Based On Availability)
- 10.2.2. Hologic, Inc.
- 10.2.2.1. Overview,
- 10.2.2.2. Products,
- 10.2.2.3. SWOT Analysis,
- 10.2.2.4. Recent Developments,
- 10.2.2.5. Strategies,
- 10.2.2.6. Financials (Based On Availability)
- 10.2.3. Boston Scientific Corporation
- 10.2.3.1. Overview,
- 10.2.3.2. Products,
- 10.2.3.3. SWOT Analysis,
- 10.2.3.4. Recent Developments,
- 10.2.3.5. Strategies,
- 10.2.3.6. Financials (Based On Availability)
- 10.2.4. ALLERGAN (AbbVie, Inc.)
- 10.2.4.1. Overview,
- 10.2.4.2. Products,
- 10.2.4.3. SWOT Analysis,
- 10.2.4.4. Recent Developments,
- 10.2.4.5. Strategies,
- 10.2.4.6. Financials (Based On Availability)
- 10.2.5. BD (Becton, Dickinson and Company)
- 10.2.5.1. Overview,
- 10.2.5.2. Products,
- 10.2.5.3. SWOT Analysis,
- 10.2.5.4. Recent Developments,
- 10.2.5.5. Strategies,
- 10.2.5.6. Financials (Based On Availability)
- 10.2.6. F. Hoffmann-La Roche Ltd
- 10.2.6.1. Overview,
- 10.2.6.2. Products,
- 10.2.6.3. SWOT Analysis,
- 10.2.6.4. Recent Developments,
- 10.2.6.5. Strategies,
- 10.2.6.6. Financials (Based On Availability)
- 10.2.7. CooperSurgical Inc. (The Cooper Companies, Inc.)
- 10.2.7.1. Overview,
- 10.2.7.2. Products,
- 10.2.7.3. SWOT Analysis,
- 10.2.7.4. Recent Developments,
- 10.2.7.5. Strategies,
- 10.2.7.6. Financials (Based On Availability)
- 10.2.8. Caldera Medical
- 10.2.8.1. Overview,
- 10.2.8.2. Products,
- 10.2.8.3. SWOT Analysis,
- 10.2.8.4. Recent Developments,
- 10.2.8.5. Strategies,
- 10.2.8.6. Financials (Based On Availability)
- 10.2.9. Reckitt Benckiser Group PLC
- 10.2.9.1. Overview,
- 10.2.9.2. Products,
- 10.2.9.3. SWOT Analysis,
- 10.2.9.4. Recent Developments,
- 10.2.9.5. Strategies,
- 10.2.9.6. Financials (Based On Availability)
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
